ROLE OF RAD9 IN BYSTANDER EFFECTS
ROLE OF RAD9 IN BYSTANDER EFFECTS
批准号:
8281638
负责人:
HOWARD B. LIEBERMAN
金额:
$33.03万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2015-06-30
关键词:
AddressApoptosisBindingBiologicalBiological AssayBystander EffectCell CycleCell Cycle CheckpointCell NucleusCell physiologyCellsCollaborationsCommunicationConnexinsCytoplasmDNA RepairDNA Repair GeneFemaleGene ExpressionGene TargetingGenesGenomic InstabilityGenotypeGoalsGrowthHealthHela CellsHumanIn VitroIncidenceIonizing radiationLeadLungMammary glandMediatingMolecularMusMutagenesisMutationNuclearPathway interactionsPlayPopulationProcessProductionPromoter RegionsProtein Binding DomainProteinsRNARadiationRadiation therapyRegulationResearch PersonnelReverse Transcriptase Polymerase Chain ReactionRiskRoleScanningSignal TransductionSmall Interfering RNATestingThinkingTimeTissuesTransactivationTransgenic OrganismsUp-RegulationWorkbaseconnexin 32embryonic stem cellgene inductionimprovedin vivoirradiationknock-downmicronucleusmutantnull mutationoverexpressionprotein functionrad9 proteinradiation effectradiation resistanceresponse
中文摘要
对电离辐射暴露的总体细胞反应不限于直接照射的细胞,
包括邻近的“旁观者”。基本上每个终点都是常规用于检测细胞变化的
直接暴露于辐射,如突变、凋亡、微核形成或细胞周期检查点,
已经在旁观者身上研究过了这一现象引起了对生物学思维的范式转变,
辐射暴露的影响和相关健康风险;受影响的细胞群大于一次
相信。调节旁观者效应的机制还不清楚。然而,某些间隙连接
蛋白质,即,连接蛋白32和蛋白质如考克斯-2控制整个过程,而p21只是调节细胞的生长。
辐射诱导的G1到S检查点。我们已经证明,Rad 9调节旁观者的反应,
辐射,因为Rad 9 null增强旁观者凋亡和微核形成。Rad 9蛋白,
控制细胞周期检查点,DNA修复,凋亡和下游靶基因的反式激活,
直接照射的细胞,可能通过一种以上的途径影响旁观者反应。合作
与项目2和项目3的研究人员一起,我们发现Rad 9对于考克斯-2的旁观者诱导是必不可少的,
p21(项目2),以及在HeLa细胞中产生连接蛋白32,其通常缺乏该蛋白,
增加旁观者辐射抗性和Rad 9以及TCTP的水平(项目3),这两者都起作用
在旁观者的过程中。我们还表明,TCTP和Rad 9物理相互作用(项目3)。我们的总体
Rad 9在辐射诱导的旁观者效应中起重要作用
涉及至少考克斯-2、p2 I、连接蛋白32和TCTP。解决这一假设的具体目标是:I。
确定Rad 9在细胞核与细胞质辐射诱导的旁观者效应中的活性; 2.
分析Rad 9功能结构域和蛋白质-蛋白质相互作用在旁观者过程中的作用; 3.
确立Rad 9依赖性旁观者诱导考克斯-2、p21等基因对旁观者的意义
监管; 4.确定Rad 9是否对旁观者诱变至关重要;以及5.定义的意义
Rad 9的调节和功能的连接通信。这些研究将揭示机制,
Rad 9调节辐射诱导的旁观者效应,并将影响对生物学的理解。
放射治疗的影响,以及对改善放射治疗和更好地确定健康风险的影响。
英文摘要
The overall cellular response to ionizing radiation exposure is not limited to cells directly irradiated, but
includes neighboring "bystanders". Essentially every endpoint used routinely to test for changes in cells
direcfiy exposed to radiation, such as mutation, apoptosis, micronuclei formation or cell cycle checkpoints,
has been studied in bystanders. This phenomenon has caused a paradigm shift in thinking about biological
effects and associated health risks of radiafion exposure; the impacted cell population is larger than once
believed. The mechanism regulating bystander effects is not well understood. However, certain gap junction
proteins, i.e., Connexin 32, and proteins like Cox-2 control the overall process, whereas p21 just regulates the
radiation-induced Gl to S checkpoint. We have shown that Rad9 regulates the bystander response to
radiation, since Rad9 null enhances bystander apoptosis and micronuclei formation. Rad9 protein, which
controls cell cycle checkpoints, DNA repair, apoptosis and transactivation of downstream target genes in
directly irradiated cells, likely impacts on the bystander response via more than one pathway. In collaboration
with investigators in Projects 2 and 3, we show that Rad9 is essential for bystander induction of Cox-2 and
p21 (Project 2), and production of Connexin 32 in HeLa cells, which are normally devoid of the protein,
increases bystander radiation resistance and levels of Rad9 as well as TCTP (Project 3), which both function
in the bystander process. We also show that TCTP and Rad9 physically interact (Project 3). Our overarching
hypothesis is that Rad9 plays an important role in radiation-induced bystander effects via mechanisms
involving at least Cox-2, p2I, Connexin 32 and TCTP. Specific aims to address this hypothesis are: I.
Determine the activity of Rad9 in nuclear versus cytoplasmic irradiation-induced bystander effects; 2.
Analyze Rad9 functional domains and protein-protein interactions for roles in the bystander process; 3.
Establish the significance of Rad9-dependent bystander induction of Cox-2, p21 and other genes for bystander
regulation; 4. Determine if Rad9 is critical for bystander mutagenesis; and 5. Define the significance of
junctional communication on the regulation and funcfion of Rad9. These studies will reveal mechanisms by
which Rad9 regulates radiation-induced bystander effects, and will impact on understanding the biological
response to radiation exposure, with implications for improving radiotherapy and better defining health risk.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROLE OF RAD9 IN BYSTANDER EFFECTS
-
批准号:7992111
-
项目类别:
-
资助金额:$75.88万
-
财政年份:2010
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Variable Dose Rate X-ray Irradiator
-
批准号:7795313
-
项目类别:
-
资助金额:$17.92万
-
财政年份:2010
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Rad9-Based Mouse Model of Prostate Carcinogenesis
-
批准号:7871480
-
项目类别:
-
资助金额:$19.92万
-
财政年份:2009
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Rad9-Based Mouse Model of Prostate Carcinogenesis
-
批准号:7728289
-
项目类别:
-
资助金额:$24.05万
-
财政年份:2009
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
RADIATION RESEARCH RESOURCE
-
批准号:7669925
-
项目类别:
-
资助金额:$5.42万
-
财政年份:2008
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Mechanisms of Radioresistance and Cell Cycle Progression
-
批准号:8115777
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2007
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Mechanisms of Radioresistance and Cell Cycle Progression
-
批准号:7902036
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2007
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Mechanisms of Radioresistance and Cell Cycle Progression
-
批准号:7386915
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2007
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Mechanisms of Radioresistance and Cell Cycle Progression
-
批准号:7667330
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2007
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Mechanisms of Radioresistance and Cell Cycle Progression
-
批准号:7502577
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2007
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Mrad9 Radioresistance Gene
-
批准号:6771164
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2001
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Mrad9 Radioresistance Gene
-
批准号:6514893
-
项目类别:
-
资助金额:$30.67万
-
财政年份:2001
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Mrad9 Radioresistance Gene
-
批准号:6607412
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2001
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
Mrad9 Radioresistance Gene
-
批准号:6399553
-
项目类别:
-
资助金额:$30.51万
-
财政年份:2001
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
The MRAD9 Radioresistance Gene
-
批准号:8443818
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2000
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
The MRAD9 Radioresistance Gene
-
批准号:7195709
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2000
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
The MRAD9 Radioresistance Gene
-
批准号:8245890
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2000
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
The MRAD9 Radioresistance Gene
-
批准号:8044877
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2000
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
The MRAD9 Radioresistance Gene
-
批准号:7093942
-
项目类别:
-
资助金额:$32.04万
-
财政年份:2000
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
The MRAD9 Radioresistance Gene
-
批准号:7596432
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2000
-
负责人:HOWARD B. LIEBERMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: